Use of peroxisome proliferator-activated receptor gamma (PPARgamma) and/or retinoic acid receptor (RXR) agonists to inhibit platelet functions

Details for Australian Patent Application No. 2004285486 (hide)

Owner University of Rochester

Inventors Phipps, Richard P.; Blumberg, Neil; Sime, Patricia J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004285486

PCT Pub. Number WO2005/041872

Priority 60/553,657 16.03.04 US; 60/567,397 30.04.04 US; 60/513,372 22.10.03 US

Filing date 22 October 2004

Wipo publication date 12 May 2005

International Classifications

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/041872 Priority application(s): WO2005/041872

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285488-Continuous water ride

2004285484-Pretreatment method and system for enhancing transdermal drug delivery